Substitute educational interpreter licenses: changes to rules [Admin.Code PI 34.095] -
CR 20-024Advance practice nurse prescribers collaboration with dentists [Admin.Code N 8.10] -
CR 18-050Delegation of functions to unlicensed persons [Admin.Code DE 12.01, 12.02, 12.04] -
CR 18-063Dental licensure and the practice of dental hygiene: requirements revised, clarifications, and obsolete provisions repealed [Admin.Code DE 2.01, 2.015, 2.03, 2.04, 2.05, 2.06, 2.07, 2.08, 2.09, 3.02, 3.03, 3.04] -
CR 17-068Dentistry: laboratory work and authorizations, sedation and anesthesia [Admin.Code DE 9.015, 9.02, 11.02, 11.025, 11.03, 11.035, 11.04, 11.05, 11.06, 11.07, 11.075, 11.08, 11.085, 11.09, 11.10] -
CR 19-132Preservation of dental patient health care records [Admin.Code DE 8.035] -
CR 18-089Electric weapons: definition and private security credential holders [Admin.Code SPS 30.02, 33.025, 34.065, 34.07, 35.01] -
CR 20-021dhsDHS, see health services department of -- specific subheading
Discrimination based on arrest or conviction record re issuing or suspending a license [Admin.Code MPSW 3.01, 3.05, 3.07, 3.09, 3.12, 3.13, 11.01, 11.04, 16.01] -
CR 19-116Absence provisions: temporary care, including child care, for immediate family members [Admin.Code ER 18.01, 18.03] -
CR 20-089Screening of newborns for congenital and metabolic disorders [Admin.Code DHS 115 (title), 115.01, 115.04] -
CR 19-064dnrDNR, see natural resources, department of -- specific subheading
doaDOA, see administration department of -- specific subheading
Dog sellers and dog facility operator licensing requirements [Admin.Code ATCP 16.01, 16.02, 16.04, 16.06, 16.08, 16.14, 16.15, 16.16, 16.18, 16.19, 16.20, 16.22, 16.24, 16.28, 16.30] -
CR 18-032dotDOT, see transportation, department of -- specific subheading
Drainage districts [Admin.Code ATCP 48.01, 48.08, 48.12, 48.14, 48.20, 48.21, 48.28 (note)] -
CR 18-052Grants to county drainage boards [Admin.Code ATCP 48.60] -
CR 19-0554-Fluoroisobutyryl fentanyl added as a schedule I controlled substance [Admin.Code CSB 2.56] -
CR 17-0894-MePPP and a-PBP added as schedule I controlled substances [Admin.Code CSB 2.52] -
CR 17-0875F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA, and MDMB-FUBINACA added as schedule I controlled substances [Admin.Code CSB 2.55] -
CR 17-0885F-EDMB-PINACA, 5FMDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 added as schedule I controlled substances [Admin.Code CSB 2.66] -
CR 20-048AB-CHMINACA, AB-PINACA, and THJ-2201 added as schedule I controlled substances [Admin.Code CSB 2.50] -
CR 17-085Brexanolone and solriamfetol added as schedule I controlled substances [Admin.Code CSB 2.67] -
CR 20-049Cenobamate added as a schedule V controlled substance [Admin.Code CSB 2.73] -
CR 20-075Community substance abuse service standards: medical services for narcotic treatment service for opiate addiction [Admin.Code DHS 75.15] -
CR 19-021Continuing medical education for physicians re opioid prescribing guidelines [Admin.Code Med 13.02, 13.03] -
CR 18-072Exclusion of [123I] ioflupane as a schedule II controlled substance [Admin.Code CSB 2.40] -
CR 16-060FDA approved cannabidiol products added as a schedule V controlled substance [Admin.Code CSB 2.65] -
CR 19-012FDA approved cannabidiol removed from schedule V and excluding FDA approved cannabidiol from schedule I [Admin.Code CSB 2.75] -
CR 20-077Flualprazolam added as schedule IV controlled substance [Admin.Code CSB 2.77] -
CR 20-079FUB-AMB added as a schedule I controlled substance [Admin.Code CSB 2.60] -
CR 18-022Gabapentin: designating as a monitored drug having a substantial potential for abuse [Admin.Code CSB 4.03] -
CR 20-080Hazardous waste, universal waste, pharmaceuticals, and used oil: generation, transportation, recycling, treatment, storage, and disposal changes; and affecting small business [Admin.Code NR 149.13 Table 2, 211.10, 211.17, 502.09, 506.095, 660.02, 660.04, 660.05, 660.10, 660.11, 660.20, 660.30, 660.31, 660.33, 660.34, 660.40, 660.41, 660.42, 660.43, 661, 661 Appendices I, VII, and VIII, 662, 663.10, 663.10 subch. A (note), 663.12, 663.20, 663.21, 663.25, 664.0001, 664.0004, 664.0012, 664.0015, 664.0052, 664.0056, 664.0071, 664.0072, 664.0101, 664.0112, 664.0143, 664.0170, 664.0174 (note), 664.0178 (note), 664.0191, 664.0193, 664.0196 (note), 664.0197, 664.0198, 664.0221, 664.0228, 664.0229, 664.0256, 664.0258, 664.0301, 664.0312, 664.0316, 664.0340, 664.0351 (note), 664.0551, 664.0552, 664.0553, 664.0554, 664.1030, 664.1050, 664.1057, 664.1064, 664.1086, 664.1101, 664.1102, 664.1200 (note), 664.1202, 665.0001, 665.0012, 665.0020, 665.0052, 665.0056, 665.0071, 665.0072, 665.0090, 665.0112, 665.0118, 665.0143, 665.0174 (note), 665.0193, 665.0195, 665.0196 (note 1), 665.0197, 665.0198, 665.0221, 665.0228, 665.0229, 665.0256, 665.0258, 665.0301, 665.0312, 665.0316, 665.0340, 665.0351 (note), 665.0381 (note), 665.0404 (note), 665.0405, 665.0440, 665.1030, 665.1050, 665.1057, 665.1063, 665.1064, 665.1087, 665.1088, 665.1101, 665.1102, 665.1202, 666.020, 666.022, 666.023 (2) (note), 666.070, 666.080, 666.100, 666.101, 666.103, 666.108, 666.112, 666.202, 666.210, 666.220, 666.255, 666.305, 666.901, 666.903, 666 [Appendices], 666 subch. P, 667.0003, 667.0071, 667.0147, 667.0201, 667.0202, 667.1108, 668.01, 668.07, 668.31, 668.37, 668.38, 668.39, 668.40, 668.40 Table, 668.45, 668.48 Table and table note 6, 668.50, 668 Appendix VI, 670.001, 670.002, 670.014, 670.019, 670.042, 670.062, 670.066, 670.320, 670.432, 670 Appendices I and II, 673.03, 673.05, 673.08, 673.13, 673.20, 673.33, 673.39, 673.40, 673.56, 673.60, 673.62, 673.70, 673.80, 679.01, 679.10, 679.11 Table 1 table note 2, 679.40] -
CR 19-082Isotonitazene and 1P-LSD added as a schedule I controlled substance [Admin.Code CSB 2.72] -
CR 20-023Lasmiditan added as a schedule V controlled substance [Admin.Code CSB 2.71] -
CR 20-058Lemborexant added as a schedule IV controlled substance [Admin.Code CSB 2.74] -
CR 20-076MAB-CHMINACA added as a schedule I controlled substance [Admin.Code CSB 2.51] -
CR 17-086Medicaid-covered services [Admin.Code DHS 107.03, 107.10] -
CR 20-063MMB-FUBICA and 4F-MDMB-BINACA added as a schedule I controlled substance [Admin.Code CSB 2.70] -
CR 20-022MT-45 added as a schedule I controlled substance [Admin.Code CSB 2.61] -
CR 18-069N-Ethylhexedrone, aPHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP added as schedule I controlled substances [Admin.Code CSB 2.68] -
CR 20-050N-ethylpentylone added as a schedule I controlled substance [Admin.Code CSB 2.64] -
CR 19-011Naldemedine excluded as a controlled substance [Admin.Code CSB 2.58] -
CR 18-024Norfentanyl added as a schedule II controlled substance [Admin.Code CSB 2.76] -
CR 20-078Noroxymorphone added as a schedule II controlled substance [Admin.Code CSB 2.69] -
CR 20-051Operation of prescription drug monitoring program [Admin.Code CSB 4.04, 4.09, 4.093, 4.11] -
CR 19-156Oral solutions containing dronabinol added as schedule II controlled substance [Admin.Code CSB 2.54] -
CR 18-055Ortho-fluorofentanyl added as a schedule I controlled substance [Admin.Code CSB 2.59] -
CR 18-023Para-chloroisobutyryl fentanyl added as a schedule I controlled substance [Admin.Code CSB 2.62] -
CR 18-070Scheduling furanyl fentanyl as a controlled substance [Admin.Code CSB 2.42] -
CR 16-059Storage of drugs and controlled substances [Admin.Code Phar 6.07, 6.075] -
CR 19-165NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA added as schedule I controlled substances [Admin.Code CSB 2.63] -
CR 19-010Frequent sobriety testing pilot program: standards and procedures [Admin.Code Jus 19] -
CR 18-068Educational approval program: revisions re 2017 WisAct 59 elimination of EAB [Admin.Code SPS 401.01, 404 (note 2), 404.01, 404.07, 404.10, 407.04] -
CR 20-004Campaign finance: revisions re 2015 WisAct 117 [Admin.Code ETH 1.20, 1.25, 1.39, 1.56, 1.60, 1.70, 1.85, 1.855] -
CR 20-010Campaign finance: updates to forms and statutory references [Admin.Code ETH 1.20, 1.26, 1.60, 1.70, 1.855, 1.96] -
CR 19-035